Deal Team

Antitrust
Executive Compensation and Benefits
Intellectual Property
Restructuring and Finance

Medtronic in its intended separation of its Patient Monitoring and Respiratory Interventions businesses

On October 24, 2022, Medtronic plc, a global leader in healthcare technology, announced its intention to pursue a separation of the company’s combined Patient Monitoring and Respiratory Interventions businesses, which are part of the company’s Medical Surgical Portfolio.

Wachtell, Lipton, Rosen & Katz served as legal advisor to Medtronic.